Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Iida

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Diabetologia|October 23, 2023
Novel time-resolved reporter mouse reveals spatial and transcriptional heterogeneity during alpha cell differentiationMiwa Himuro, Yuka Wakabayashi, Tomomi Taguchi, et al.
Metabolites|September 27, 2023
Effects of Exercise on Functional Recovery in Patients with Bipolar Depression: A Study Protocol for a Randomized Controlled TrialFumito Hamada, Hikaru Hori, Hitoshi Iida, et al.
Diabetologia|August 3, 2023
SERCA2 regulates proinsulin processing and processing enzyme maturation in pancreatic beta cellsHitoshi Iida, Tatsuyoshi Kono, Chih-Chun Lee, et al.
BMC Psychiatry|October 9, 2025
Maintenance pharmacotherapy after electroconvulsive therapy in inpatients with major depressive disorder: 198 prescriptions in a real-world clinical settingShun Igarashi, Takashi Tsuboi, Naomi Hasegawa, et al.
The International Journal of Neuropsychopharmacology|March 28, 2025
Associations between clozapine availability, the diagnosis of treatment-resistant schizophrenia subgroups, antipsychotic monotherapy, and concomitant psychotropics among patients with schizophrenia: a real-world nationwide studyShinichiro Ochi, Fumitoshi Kodaka, Naomi Hasegawa, et al.
Psychiatry and Clinical Neurosciences|May 16, 2018
Polypharmacy and psychotropic drug loading in patients with schizophrenia in Asian countries: Fourth survey of Research on Asian Prescription Patterns on antipsychoticsShu-Yu Yang, Lian-Yu Chen, Eunice Najoan, et al.
Neuropsychopharmacology Reports|December 2, 2021
Association between the examination rate of treatment-resistant schizophrenia and the clozapine prescription rate in a nationwide dissemination and implementation studyNorio Yasui-Furukori, Hiroyuki Muraoka, Naomi Hasegawa, et al.
Asian Journal of Psychiatry|July 29, 2021
Characteristics of discharge prescriptions for patients with schizophrenia or major depressive disorder: Real-world evidence from the Effectiveness of Guidelines for Dissemination and Education (EGUIDE) psychiatric treatment projectNaoki Hashimoto, Norio Yasui-Furukori, Naomi Hasegawa, et al.
Psychiatry Research|March 20, 2019
Clozapine prescription pattern in patients with schizophrenia in Asia: The REAP survey (2016)Shi-Wei Xu, Min Dong, Qinge Zhang, et al.
BMC Psychiatry|May 28, 2024
The effect of education regarding treatment guidelines for schizophrenia and major depressive disorders on psychiatrists' hypnotic medication prescribing behavior: a multicenter studyToshinori Nakamura, Ryuji Furihata, Naomi Hasegawa, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Diabetologia|October 23, 2023
Novel time-resolved reporter mouse reveals spatial and transcriptional heterogeneity during alpha cell differentiationMiwa Himuro, Yuka Wakabayashi, Tomomi Taguchi, et al.
Metabolites|September 27, 2023
Effects of Exercise on Functional Recovery in Patients with Bipolar Depression: A Study Protocol for a Randomized Controlled TrialFumito Hamada, Hikaru Hori, Hitoshi Iida, et al.
Diabetologia|August 3, 2023
SERCA2 regulates proinsulin processing and processing enzyme maturation in pancreatic beta cellsHitoshi Iida, Tatsuyoshi Kono, Chih-Chun Lee, et al.
BMC Psychiatry|October 9, 2025
Maintenance pharmacotherapy after electroconvulsive therapy in inpatients with major depressive disorder: 198 prescriptions in a real-world clinical settingShun Igarashi, Takashi Tsuboi, Naomi Hasegawa, et al.
The International Journal of Neuropsychopharmacology|March 28, 2025
Associations between clozapine availability, the diagnosis of treatment-resistant schizophrenia subgroups, antipsychotic monotherapy, and concomitant psychotropics among patients with schizophrenia: a real-world nationwide studyShinichiro Ochi, Fumitoshi Kodaka, Naomi Hasegawa, et al.
Psychiatry and Clinical Neurosciences|May 16, 2018
Polypharmacy and psychotropic drug loading in patients with schizophrenia in Asian countries: Fourth survey of Research on Asian Prescription Patterns on antipsychoticsShu-Yu Yang, Lian-Yu Chen, Eunice Najoan, et al.
Neuropsychopharmacology Reports|December 2, 2021
Association between the examination rate of treatment-resistant schizophrenia and the clozapine prescription rate in a nationwide dissemination and implementation studyNorio Yasui-Furukori, Hiroyuki Muraoka, Naomi Hasegawa, et al.
Asian Journal of Psychiatry|July 29, 2021
Characteristics of discharge prescriptions for patients with schizophrenia or major depressive disorder: Real-world evidence from the Effectiveness of Guidelines for Dissemination and Education (EGUIDE) psychiatric treatment projectNaoki Hashimoto, Norio Yasui-Furukori, Naomi Hasegawa, et al.
Psychiatry Research|March 20, 2019
Clozapine prescription pattern in patients with schizophrenia in Asia: The REAP survey (2016)Shi-Wei Xu, Min Dong, Qinge Zhang, et al.
BMC Psychiatry|May 28, 2024
The effect of education regarding treatment guidelines for schizophrenia and major depressive disorders on psychiatrists' hypnotic medication prescribing behavior: a multicenter studyToshinori Nakamura, Ryuji Furihata, Naomi Hasegawa, et al.
Pageof 6